Health
New clinical trial shows combination of two innovative precision medicines could treat multiple cancers – News-Medical.Net
Launching a dual-pronged attack on tumours using a combination of two innovative precision medicines could treat patients with multiple common cancers, a new clinical trial shows.
Launching a dual-pronged attack on tumours using a combination of two innovative precision medicines could treat patients with multiple common cancers, a new clinical trial shows.
It is the first trial to use the pioneering genetically targeted drug olaparib – already licensed for ovarian, breast and prostate cancer – together with a promising new medicine, called capivasertib.
The researchers used the drug combination to target two fundamental weaknesses in cancer at the same time – a damaged…
-
General24 hours agoFederal government funding extends cohealth GP services until July 2026
-
General8 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
Noosa News22 hours agoSunshine Coast Airport receives green light for major upgrade opening doors to growth jobs and tourism across the region
-
General11 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique